Machine generated contents note: 1.Small Molecule Bromodomain Inhibitors: Extending the Druggable Genome / Chun-wa Chung -- 2.TRPV1 Antagonists: Clinical Setbacks and Prospects for Future Development / Philip R. Kym -- 3.Multivalent Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) Molecules for the Treatment of COPD / Tod Steinfeld -- 4.Hematopoietic Prostaglandin D Synthase Inhibitors / Sukanthini Thurairatnam.
Summary
Annual Review of Eclectic Developments in Medicinal Chemistry Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry.